Pharmaceutical formulation of some radiolabeled pharmaceutical compounds for possible use as a model in cancer imaging and therapy / Mohamed Hodhod Elsayed Mohamed Aboumanei ; Supervised Ahmed Abdelbary , Mohamed Taha Hussein Elkolaly
Material type: TextLanguage: English Publication details: Cairo : Mohamed Hodhod Elsayed Mohamed Aboumanei , 2014Description: 172 P. : charts , facsimiles ; 30cmOther title:- الصياغة الصيدلية لبعض المركبات الصيدلانيه المرقمه اشعاعيا لإمكانية إستخدامها كنموذج فى تصوير وعلاج السرطان [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Thesis | قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.08.08.M.Sc.2014.Mo.P (Browse shelf(Opens below)) | Not for loan | 01010110065609000 | |||
CD - Rom | مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.08.08.M.Sc.2014.Mo.P (Browse shelf(Opens below)) | 65609.CD | Not for loan | 01020110065609000 |
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics
Early detection of cancer through screening based on imaging is probably the major contributor to a reduction in mortality for certain cancers. Targeted imaging or therapy of receptors, gene therapy expression and cancer stem cells are research activities that will translate into clinical use in the next decade. The use of various contrast agents and radiotracers for cancer imaging and therapy are reviewed, as are the current limitations of ultrasound, x-ray imaging, and magnetic resonance imaging (MRI), and single-photon emission computed tomography, positron emission tomography (PET), and optical imaging. The lack of selectivity of chemotherapeutic anticancer agent also is still a serious drawback in conventional cancer chemotherapy
Issued also as CD
There are no comments on this title.